ZA201503799B - Fixed dose pharmaceutical composition comprising mometasone and azelastine - Google Patents

Fixed dose pharmaceutical composition comprising mometasone and azelastine

Info

Publication number
ZA201503799B
ZA201503799B ZA2015/03799A ZA201503799A ZA201503799B ZA 201503799 B ZA201503799 B ZA 201503799B ZA 2015/03799 A ZA2015/03799 A ZA 2015/03799A ZA 201503799 A ZA201503799 A ZA 201503799A ZA 201503799 B ZA201503799 B ZA 201503799B
Authority
ZA
South Africa
Prior art keywords
azelastine
mometasone
pharmaceutical composition
fixed dose
dose pharmaceutical
Prior art date
Application number
ZA2015/03799A
Other languages
English (en)
Inventor
Piyush Agarwal
Suresh Rajurkar
Sunil Chaudhari
Ulhas Dhuppad
Original Assignee
Glenmark Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from BR102013000830A external-priority patent/BR102013000830A2/pt
Application filed by Glenmark Pharmaceuticals Ltd filed Critical Glenmark Pharmaceuticals Ltd
Publication of ZA201503799B publication Critical patent/ZA201503799B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ZA2015/03799A 2012-12-06 2015-05-27 Fixed dose pharmaceutical composition comprising mometasone and azelastine ZA201503799B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN3454MU2012 2012-12-06
BR102013000830A BR102013000830A2 (pt) 2013-01-11 2013-01-11 Composição farmacêutica para administração nasal, e, uso da mesma
PCT/IB2013/060638 WO2014087347A1 (en) 2012-12-06 2013-12-04 Fixed dose pharmaceutical composition comprising mometasone and azelastine

Publications (1)

Publication Number Publication Date
ZA201503799B true ZA201503799B (en) 2016-02-24

Family

ID=50882873

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2015/03799A ZA201503799B (en) 2012-12-06 2015-05-27 Fixed dose pharmaceutical composition comprising mometasone and azelastine

Country Status (7)

Country Link
EP (1) EP2928302A1 (ru)
EA (1) EA037259B1 (ru)
MX (2) MX2014003546A (ru)
MY (1) MY196902A (ru)
PH (1) PH12015501179A1 (ru)
WO (1) WO2014087347A1 (ru)
ZA (1) ZA201503799B (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109288790A (zh) * 2017-07-25 2019-02-01 健乔信元医药生技股份有限公司 鼻用医药组合物及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2389530B (en) * 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
US20070020330A1 (en) * 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof

Also Published As

Publication number Publication date
MY196902A (en) 2023-05-09
PH12015501179A1 (en) 2015-08-17
MX2014003546A (es) 2014-12-09
WO2014087347A1 (en) 2014-06-12
MX2019001701A (es) 2019-08-14
EA037259B1 (ru) 2021-03-01
EP2928302A1 (en) 2015-10-14
EA201491769A1 (ru) 2015-06-30

Similar Documents

Publication Publication Date Title
IL274988A (en) Carbamoylpyridone-polycyclic compounds and their pharmaceutical use
HK1205690A1 (en) Pharmaceutical composition and administration thereof
IL252566B (en) Pharmacy preparations and methods
IL236024A (en) The history of benzimidazole-proline and its pharmaceutical preparations
PT3043773T (pt) Composição farmacêutica de dose fixa estável composta por mometasona e olopatadina para administração nasal
IL237841A0 (en) Alpha hydroxy amides and pharmaceutical preparations containing them
ZA201409508B (en) Pharmaceutical composition comprising fimasartan and hydrochlorothiazide
HK1203050A1 (en) Novel dosage and formulation
GB2504390B (en) Nutraceutical and pharmaceutical composition
ZA201504512B (en) Pharmaceutical composition comprising desloratadine and prednisolone and use thereof
HK1186106A1 (zh) 含有己酮可可碱和普卡必利的藥物組合物及其醫藥用途
ZA201503799B (en) Fixed dose pharmaceutical composition comprising mometasone and azelastine
GB201208315D0 (en) Pharmaceutical methods and compositions